Cost-effectiveness of primary prevention implantable cardioverter defibrillator treatment: data from a large clinical registry.
about
The Wearable Cardioverter/Defibrillator - Toy Or Tool?Cost-Effectiveness of Cetuximab for Advanced Esophageal Squamous Cell CarcinomaCost-effectiveness of implantable cardioverter-defibrillator in today's world.Ventricular arrhythmias and sudden cardiac death in adults with congenital heart disease.The mismatch between patient life expectancy and the service life of implantable devices in current cardioverter-defibrillator therapy: a call for larger device batteries.
P2860
Cost-effectiveness of primary prevention implantable cardioverter defibrillator treatment: data from a large clinical registry.
description
2013 nî lūn-bûn
@nan
2013 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Cost-effectiveness of primary ...... rom a large clinical registry.
@ast
Cost-effectiveness of primary ...... rom a large clinical registry.
@en
type
label
Cost-effectiveness of primary ...... rom a large clinical registry.
@ast
Cost-effectiveness of primary ...... rom a large clinical registry.
@en
prefLabel
Cost-effectiveness of primary ...... rom a large clinical registry.
@ast
Cost-effectiveness of primary ...... rom a large clinical registry.
@en
P2093
P2860
P356
P1476
Cost-effectiveness of primary ...... from a large clinical registry
@en
P2093
C Jan Willem Borleffs
Enno T van der Velde
Joep Thijssen
Johannes B van Rees
Lieselot van Erven
Martin J Schalij
Mihály K de Bie
P2860
P356
10.1111/PACE.12238
P577
2013-09-02T00:00:00Z